(DVCA) Notification on Corporate Action "Cash Dividend" - Takeda Pharmaceutical Company Ltd ORD SHS ADR (depositary receipts ISIN US8740602052)
Corporate Action Information
Corporate Action Reference
526417
Corporate Action Type Code
DVCA
Corporate Action Type
Cash Dividend
Mandatory indicator
MAND Mandatory
Value date
11 dec 2020
Security Details
Corporate Action Security Reference
Issuer
Security Name
Category
NSD Code
ISIN
Underlying Security Issuer
Underlying Security Type
Ratio ( Number of DR/ Number of Underlying Securities)
526417D250
BNY Mellon
Takeda Pharmaceutical Company Ltd ORD SHS ADR
American depository receipt
US8740602052
US8740602052
Takeda Pharmaceutical Company Limited
shares ordinary
2 : 1
Corporate Action Details
Record Date
30 sep 2020
National Settlement Depository (NSD) notifies that the additional information regarding Cash Dividend has been received from
International Settlement and Clearing Organization. Value date has been announced. Detailed information regarding this corporate action event will be provided to holders who have balances of these securities
on their safekeeping accounts with NSD.
If you have any questions related to this communication, please contact your account managers at NSD by telephone: +7 495 956-27-90 or +7 495 956-27-91.
Print page
NSD processes cookies to personalise its services and make www.nsddata.ru more user-friendly.
By clicking the «Accept»
button, you consent to the processing of cookies.
You can refuse the processing of cookies by changing your browser settings.